Inogen

Inogen EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Inogen (INGN) as of Nov 4, 2026 is 33.78 %. In the previous year, Year-over-Year EBITDA Growth was 64.70 % — a change of -47.79% (lower).

EBITDA Growth YoY

33.78 %

YoY

-47.79%

Last updated:

Year-over-Year EBITDA Growth of Inogen is 2025 33.78 % . Year-over-Year EBITDA Growth of Inogen was 2024 64.70 % . It decreases by -47.79% lower compared to the previous year.

The Inogen EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2018
37.34 USD
Jan 1, 2019
-47.78 USD
Jan 1, 2020
-160.77 USD
Jan 1, 2021
250.02 USD
Jan 1, 2022
-525.40 USD
Jan 1, 2023
-40.97 USD
Jan 1, 2024
64.70 USD
Jan 1, 2025
33.78 USD
The Inogen EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
33.78 %-47.79%
64.70 %-257.93%
-40.97 %-92.20%
-525.40 %-310.14%
250.02 %-255.52%
-160.77 %+236.50%
-47.78 %-227.95%
37.34 %+80.65%
20.67 %-60.18%
51.91 %+20.18%
43.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

Year-over-Year EBITDA Growth of Inogen is 33.78 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Inogen since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Inogen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Inogen

All Key Metrics — Inogen